Nexgel Dividend Coverage

What does Nexgel do? NexGel Inc. generates revenue through the sale of proprietary aqueous polymer hydrogels manufactured using electron beam cross-linking technology. The company markets MedaGel for over-the-counter wound care products like blister and pain remedies, and LumaGel Beauty for cosmetic applications including wrinkle and skin creams. Its customers, primarily healthcare providers and cosmetic brands, purchase these branded gels for integration into their own product lines. NexGel's manufacturing focuses on high water content hydrogels tailored to medical and beauty segments through custom formulations based on its proprietary technologies. The firm's MedaGel brand targets the OTC medical segment with solutions for wound care and pain relief, while LumaGel Beauty serves the cosmetics market with skincare products. Both brands leverage NexGel's proprietary mixing, coating, and crosslinking technologies to produce gels sold to customers who then market them under their own labels. The company's revenue streams derive from direct sales of these branded gels to manufacturers who incorporate them into final consumer products for the U.S. and international markets. NexGel's product portfolio centers on hydrogels for wound care, diagnostics, drug delivery, and cosmetics, with MedaGel and LumaGel Beauty representing its two primary brand segments. The company's manufacturing expertise in custom gels allows it to serve both medical and beauty industries through its branded product lines. Revenue is generated through the sale of these branded gels to customers who then distribute them as part of their own branded offerings in the U.S. and global markets. Nexgel is one of the most popular companies on Eulerpool.